RxDoctor Payments Data

Steven Markowitz, MD

Clinical Cardiac Electrophysiology · New York, NYNPI 1467549535

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $131,837 of the $149,697 with a category attached, or 88.1%. Boston Scientific accounts for 84.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $52,339 and has fallen 75.3% since, to $12,949 in 2025. Among clinical cardiac electrophysiology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$149,697in general payments, 2019–2025

Across 242 payments — averaging $618.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$126K
  • ZOLL Respicardia, Inc.$7K
  • Biotronik Inc.$7K
  • Medtronic$4K
  • Abbott$3K
  • Biosense Webster, Inc.$666
  • plus $1K from 9 others
$710,153in research payments, 2019–2025

Across 161 payments — averaging $4410.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$431K
  • Medtronic$168K
  • Abbott$111K

What the payments were for

  • Consulting fees$131,83788%
  • Speaking & faculty fees$3,0002%
  • Grants$6,0004%
  • Travel & lodging$3,3692%
  • Food & beverage$5,3924%
  • Entertainment$990%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$149,697 in reported general payments places this provider in the 90th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York

Medicare billing

Part B allowed, 2024
$369,225
Medicare patients
867
Services billed
3,318

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban187$184,378
MultaqDronedarone Hcl59$84,614
Dofetilide74$38,921
XareltoRivaroxaban40$38,660
Propafenone Hcl ErPropafenone Hcl22$7,022
Amiodarone Hcl58$2,208
Metoprolol Succinate86$1,393
Flecainide Acetate21$1,094
Diltiazem 24hr Er (Cd)Diltiazem Hcl23$747
Metoprolol Tartrate15$97

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →